Byrd, K. and Truong, P. (2014) “Bortezomib in the Treatment of Acquired von Willebrand Disease Secondary to Monoclonal Gammopathy of Undetermined Significance”, Kansas Journal of Medicine, 7(4), pp. 167–170. doi:10.17161/kjm.v7i4.11507.